According to Alembic Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $75.56 M. In 2022 the company made an earning of $39.33 M a decrease over its 2021 earnings that were of $0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $75.56 M | 92.08% |
2022 | $39.33 M | -67.23% |
2021 | $0.12 B | -34.41% |
2020 | $0.18 B | 42.14% |
2019 | $0.12 B | 18.16% |
2018 | $0.10 B | 36.49% |
2017 | $79.83 M | -1.15% |
2016 | $80.76 M | -41.82% |
2015 | $0.13 B | 139.55% |
2014 | $57.95 M | 14.1% |
2013 | $50.79 M |